| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Mar―13 |
Amelioration of COVID-19 comorbid depressions via interleukin 6 with agomelatine |
Yang I. Cao |
| 2 |
[GO] |
2025―Feb―10 |
COVID 19 and autoimmune blistering diseases: is there a link between epidermolysis bullosa acquisita and SARS-CoV-2? |
|
| 3 |
[GO] |
2025―Feb―10 |
Contribution of mast cells in SARS-CoV-2-induced inflammation |
G. Ronconi |
| 4 |
[GO] |
2025―Feb―10 |
Developing a Subunit Vaccine against SARS-CoV-2 Using Bioinformatics Insights on Cytotoxic T-Lymphocytes (CTLs) Epitopes |
|
| 5 |
[GO] |
2025―Feb―10 |
A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly. |
L. Englmeier |
| 6 |
[GO] |
2025―Feb―10 |
Be aware of SARS-CoV-2 spike protein: There is more than meets the eye. |
T.C. Theoharides |
| 7 |
[GO] |
2025―Feb―10 |
Pan-Virome of Third Wave SARS-CoV-2 Strains in Pakistan Reveals Higher Entropy |
|
| 8 |
[GO] |
2025―Feb―10 |
CRISPR-Cas-based assays for the detection of SARS-CoV-2 RNA |
T. Ito |
| 9 |
[GO] |
2025―Feb―10 |
A case of myocarditis in a child with Multisystem Inflammatory Syndrome (MIS-C) related to previous Sars-CoV-2 infection: Our experience |
|
| 10 |
[GO] |
2025―Feb―10 |
Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study. |
S. Marini |
| 11 |
[GO] |
2025―Feb―10 |
SARS-CoV-2 infection versus the body immune defenses: the role of immune responses and mechanism of action of dexamethasone |
I.Z. Sadiq |
| 12 |
[GO] |
2025―Feb―10 |
Evaluation of IgG seroprevalence of the Sars-Cov-2 in different worker categories |
E. Toniato |
| 13 |
[GO] |
2025―Feb―10 |
Early rehabilitation program in SARS-CoV-2 hospitalized patients during the first lock-down: an Italian experience |
R. Saggini |
| 14 |
[GO] |
2025―Feb―10 |
Peptide sharing between SARS-CoV-2 and Bullous pemphigoid 180 |
|
| 15 |
[GO] |
2025―Feb―10 |
Environment and COVID: the consequence of exposure to air pollutants on the pathology of SARS-COV-2 |
C. Petrarca |
| 16 |
[GO] |
2025―Feb―10 |
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. |
S.K. Kritas |
| 17 |
[GO] |
2025―Feb―10 |
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem |
P. Conti |
| 18 |
[GO] |
2025―Feb―10 |
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. |
P. Conti |
| 19 |
[GO] |
2025―Feb―10 |
Diagnosis and treatment of two patients with novel coronavirus pneumonia combined with acute stress disorder |
X-Y. Duan |
| 20 |
[GO] |
2025―Feb―10 |
Phageome based vaccination and human innate immune modulation could be a useful strategy to control human Coronavirus infections |
M. Abaidullah |
| 21 |
[GO] |
2025―Feb―10 |
5G Technology and induction of coronavirus in skin cells. |
M. Fioranelli |
| 22 |
[GO] |
2025―Feb―10 |
RETRACTED: 5G Technology and induction of coronavirus in skin cells |
M. Fioranelli |
| 23 |
[GO] |
2025―Feb―10 |
Physicochemical Characterization of Antiviral Phytochemicals of Artemisia annua Plant as Therapeutic Potential against Coronavirus Disease: In Silico-Drug Delivery by Density Functional Theory Benchmark |
|
| 24 |
[GO] |
2025―Feb―10 |
Risk Factors Associated with Coronavirus Disease 2019-Related Hospitalization in Rheumatoid Arthritis Patients |
|
| 25 |
[GO] |
2025―Feb―10 |
Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
P. Conti |
| 26 |
[GO] |
2025―Feb―10 |
Latex allergy: advantages of molecular diagnostics during coronavirus |
M. De Amici |
| 27 |
[GO] |
2025―Feb―10 |
Dexamethasone for COVID-19? Not so fast. |
T.C. Theoharides |
| 28 |
[GO] |
2025―Feb―10 |
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. |
Pio Conti |
| 29 |
[GO] |
2025―Feb―10 |
Glycyrrhizin for topical use and prophylaxis of COVID-19: an interesting pharmacological perspective |
D. Passali |
| 30 |
[GO] |
2025―Feb―10 |
Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment |
A. Varricchio |
| 31 |
[GO] |
2025―Feb―10 |
Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment |
A. Varricchio |
| 32 |
[GO] |
2025―Feb―10 |
Occupational asthma and COVID-19: a review |
A. Lumaca |
| 33 |
[GO] |
2025―Feb―10 |
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. |
P. Conti |
| 34 |
[GO] |
2025―Feb―10 |
Anaphylaxis is a rare reaction in COVID-19 vaccination. |
R.G. Bellomo |
| 35 |
[GO] |
2025―Feb―10 |
A bioprogressive approach for post-acute rehabilitation in elderly COVID-19 survivors |
R. Saggini |
| 36 |
[GO] |
2025―Feb―10 |
How to classify the covid-19 phenotype: a response from “the first soldier in the first trench” in Lombardy, north-western Italy |
C.E. Gallenga |
| 37 |
[GO] |
2025―Feb―10 |
Clinical and diagnostic findings in COVID-19 patients: an original research from SG Moscati Hospital in Taranto Italy |
M. Balzanelli |
| 38 |
[GO] |
2025―Feb―10 |
Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study |
YY. Hu |
| 39 |
[GO] |
2025―Feb―10 |
Latex PPE-induced reactions during the Covid-19 pandemic: gender and previous allergies as distinctive predisposing factors among healthcare workers |
G. Spatari |
| 40 |
[GO] |
2025―Feb―10 |
Compliance of children with removable functional appliance with microchip integrated during covid-19 pandemic: a systematic review |
V. Montenegro |
| 41 |
[GO] |
2025―Feb―10 |
Approach to skin malignancies in COVID-19 pandemic days. |
M. Aslan Kayıran |
| 42 |
[GO] |
2025―Feb―10 |
Approach to skin malignancies in COVID-19 pandemic days. |
M.A. Kayiran |
| 43 |
[GO] |
2025―Feb―10 |
Airborne contamination during a full-mouth disinfection session: Pilot study before COVID-19 pandemic |
F. Esposito |
| 44 |
[GO] |
2025―Feb―10 |
Neurosurgical and craniofacial surgery during the Covid-19 pandemic |
|
| 45 |
[GO] |
2025―Feb―10 |
Orthodontic emergencies and patients’ perceptions of orthodontic patients during the COVID-19 pandemic |
|
| 46 |
[GO] |
2025―Feb―10 |
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders |
|
| 47 |
[GO] |
2025―Feb―10 |
Impact of Covid-19 on front office-related stress |
L. Di Giampaolo |
| 48 |
[GO] |
2025―Feb―10 |
COVID-19 ocular manifestation in children |
|
| 49 |
[GO] |
2025―Feb―10 |
Adoptive Transfer of Regulatory T Cells Induced by Pregnancy May Mitigate the Severity of COVID-19 Infection in Pregnant Women |
|
| 50 |
[GO] |
2025―Feb―10 |
COVID-19 infection and survival in patients with spontaneous intracerebral haemorrhage |
|
| 51 |
[GO] |
2025―Feb―10 |
Facial Mask and Plexiglass Box: a critical overview on the current strategies to protect patients from COVID-19 infection |
D. De Vito |
| 52 |
[GO] |
2025―Feb―10 |
Periodontal disease and clinical association with COVID-19 infection |
|
| 53 |
[GO] |
2025―Feb―10 |
Monoclonal antibody therapy in COVID-19 induced by SARS-CoV-2. |
P. Conti |
| 54 |
[GO] |
2025―Feb―10 |
Monoclonal antibody therapy in COVID-19 induced by SARS-CoV-2. |
P. Conti |
| 55 |
[GO] |
2025―Feb―10 |
Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall? |
A. Goren |
| 56 |
[GO] |
2025―Feb―10 |
Assessment of the Immunogenicity of COVID-19 Heterogeneous Booster Vaccination Following the Full Immunization of Inactivated Vaccines |
|
| 57 |
[GO] |
2025―Feb―10 |
Lactoferrin: a potential candidate to fight respiratory infections in the pandemic COVID-19 era |
D. Passali |
| 58 |
[GO] |
2025―Feb―10 |
Prevention and treatment of upper respiratory diseases in the pandemic COVID-19 era |
D. Passali |
| 59 |
[GO] |
2025―Feb―10 |
Personal protective equipments and occupational stress in covid-19 era |
R. Mangifesta |
| 60 |
[GO] |
2025―Feb―10 |
Increased burnout risk in health workers in the covid-19 era |
C. Petrarca |
| 61 |
[GO] |
2025―Feb―10 |
Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter? |
C. Sitzia |
| 62 |
[GO] |
2025―Feb―10 |
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). |
P. Conti |
| 63 |
[GO] |
2025―Feb―10 |
SARS-CoV-2, which induces COVID-19, causes Kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines. |
G. Ronconi |
| 64 |
[GO] |
2025―Feb―10 |
COVID-19 and Multisystem Inflammatory Syndrome, or is it mast cell activation syndrome? |
T.C. Theoharides |
| 65 |
[GO] |
2025―Feb―10 |
Interleukin-6 as unfavorable prognostic factor in patients affected by Covid-19 and hip fracture |
A. Pantalone |
| 66 |
[GO] |
2025―Feb―10 |
Exploration of Potential Biomarkers and Mechanisms for COVID-19 and Asthma Based on Microarray Analysis |
|
| 67 |
[GO] |
2025―Feb―10 |
Pediatric COVID-19 - a review |
|
| 68 |
[GO] |
2025―Feb―10 |
On Water Pollution in Agriculture and COVID-19 |
M. Mcheik |
| 69 |
[GO] |
2025―Feb―10 |
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. |
P. Conti |
| 70 |
[GO] |
2025―Feb―10 |
Role of the hemostasis system in COVID-19 |
AV. Logunov |
| 71 |
[GO] |
2025―Feb―10 |
Potential Role of Zinc, an Essential Trace Element with Antioxidant Properties in the Prevention and Management of COVID-19 |
|
| 72 |
[GO] |
2025―Feb―10 |
Alteration of the perception of cold, heat and texture of food in association with taste dysfunction in COVID-19 |
|
